SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-010463
Filing Date
2017-09-11
Accepted
2017-09-11 16:31:23
Documents
61
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 792220
2 ex31-1.htm EX-31.1 11395
3 ex31-2.htm EX-31.2 10947
4 ex32-1.htm EX-32.1 5522
5 ex32-2.htm EX-32.2 5398
  Complete submission text file 0001493152-17-010463.txt   3082224

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adxs-20170731.xml EX-101.INS 397177
7 XBRL SCHEMA FILE adxs-20170731.xsd EX-101.SCH 44531
8 XBRL CALCULATION FILE adxs-20170731_cal.xml EX-101.CAL 62449
9 XBRL DEFINITION FILE adxs-20170731_def.xml EX-101.DEF 91408
10 XBRL LABEL FILE adxs-20170731_lab.xml EX-101.LAB 289703
11 XBRL PRESENTATION FILE adxs-20170731_pre.xml EX-101.PRE 201189
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 171079283
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences